Clinical trial
An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
NCT00127647 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00127647 |
|---|---|
| Title | An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) |
| Official title | MK0476 Phase III Double-Blind Comparative Study - Allergic Rhinitis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | montelukast sodium, Comparator: pranlukast |
| Enrollment | 1,375 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Aug 8, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: